Nano Sensing for Early Diagnosis of Pancreatic Cancer

Author:

Krishna Sidarth,McClelland Arthur,Zeng Tingying Helen

Abstract

AbstractPancreatic Cancer is becoming the second leading cause of cancer deaths, mainly attributed to late diagnosis. Surgical resection remains the only plausible treatment for curing patients of this cancer, but this is only possible when the cancer is localized making early detection vital. Currently, the most common early diagnostic method is the tri-phasic pancreatic-protocol CT scan. This method however has a low accuracy and specificity making it an ineffective early diagnostic. This purpose of this research was to develop a non-invasive, fast, and highly sensitive early diagnostic method for pancreatic cancer through the applications of nanotechnology. Surface Enhanced Raman Spectroscopy (SERS) is an innovative nano sensing method which results from plasmonic effect through molecules interacting with the surface of metal nanoparticles. This is a new method for trace biomarker detections and shows great potential to be an early nano-diagnostic method for Pancreatic cancer. This project uses Leucine as a biomarker for the demonstration of SERS for early pancreatic cancer detection. This is because recent studies show that Leucine has linked its overexpression with pancreatic cancer; studies have found a specificity of 100% with the use of Leucine and early diagnosis 2 to 5 years earlier than current diagnostic methods for pancreatic cancer. The parameters for SERS enhancement were optimized for the detection of Leucine using 20 nm Ag NPs. Predictive curves with linear fits were generated from an analysis of feature peaks giving the highest sensitivity for trace concentrations. This new finding shows the promising development of an early diagnostic method that is non-invasive, efficient and highly accurate for pancreatic cancer through SERS nano sensing.

Publisher

Cold Spring Harbor Laboratory

Reference19 articles.

1. Advances in pancreatic cancer biomarkers;Oncology reviews,2019

2. Pancreatic cancer

3. Key Statistics for Pancreatic Cancer. (2022, January 21). American Cancer Society. https://www.cancer.org/cancer/pancreatic-cancer/about/key-statistics.html

4. Pancreatic cancer - Symptoms and causes. (2021, June 6). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/pancreatic-cancer/symptoms-causes/syc-20355421

5. Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma;Cancers,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3